Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. Februar 2016 05:01 ET | Quelle: Affimed N.V.

Affimed to Present at the Leerink Partners 5th Annual Global Healthcare Conference

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, February 4, 2016...
25. Januar 2016 05:00 ET | Quelle: Affimed N.V.

Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Hodgkin Lymphoma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, January 25, 2016 -...
21. Januar 2016 10:00 ET | Quelle: Affimed N.V.

Affimed Appoints Dr. Joerg Windisch as Chief Operating Officer and Adds Dr. Bernhard Ehmer to Supervisory Board

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, January 21, 2016 -...
20. Januar 2016 05:00 ET | Quelle: Affimed N.V.

Affimed to Host Hodgkin's Lymphoma Day with Key Opinion Leaders on January 26th in New York City

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, January 20, 2016 - Affimed...
14. Januar 2016 05:00 ET | Quelle: Affimed N.V.

Affimed Announces Addition of Dr. Andrew Evens to Scientific Advisory Board

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, January 14, 2016 -...
12. Januar 2016 05:00 ET | Quelle: Affimed N.V.

Affimed to Present at Noble Financial Capital Markets' 12th Annual Investor Conference

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, January 12, 2016 -...
14. Dezember 2015 05:00 ET | Quelle: Affimed N.V.

Affimed Added to NASDAQ Biotech Index®

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, December 14, 2015 -...
06. Dezember 2015 09:00 ET | Quelle: Affimed N.V.

Affimed Presents Data Comparing T-cell- and NK-cell-engaging TandAbs AFM11 and AFM12 at ASH

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} -- Differentiated Product Profiles Provide...
06. Dezember 2015 09:00 ET | Quelle: Affimed N.V.

Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} -- Data Indicate AFM13 / anti-PD-1...
02. Dezember 2015 05:00 ET | Quelle: Affimed N.V.

Affimed Announces Appointment of Andrew Curtis to Lead Corporate Strategy and Business Development, Expansion of US Presence

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Heidelberg, Germany, December 2, 2015...

Vorherige Seite